Cabinet’s refusal protected Ghanaians’ medical files, but analysts say the country still lacks the systems to keep that data safe at home.
Ghana walked away from a proposed health funding agreement with the United States because of what the deal asked for in return: access to the country's pathogen samples and citizens' medical records.
President John Mahama set out the reasons for the Cabinet decision on 25 September 2026 at the Council on Foreign Relations in New York. The compact had been framed as a replacement for health money lost when the United States Agency for International Development (USAID) wound down its support to Ghana.
What was reportedly on offer
The text of the draft agreement has not been made public, so the figures in circulation come from the President's account and from press reporting. Reuters has been cited as putting the direct American funding at $109 million over five years, while one Ghanaian outlet described a wider framework of roughly $300 million with Ghana covering the balance.
According to the President, two further conditions were attached: a cash contribution from Ghana, and a restriction preventing the Food and Drugs Authority (FDA), the national regulator for medicines and food safety, from inspecting products imported under the arrangement.
The cost of saying no
The refusal is not free. Mr Mahama said $174 million already programmed into the national budget has been withdrawn, leaving an annual shortfall of about $74 million in health financing. That gap falls on the same clinics that depend on donor-funded commodities for HIV and other programmes.
He tied the decision to the Accra Reset, an initiative pushing for African-made medicines and vaccines as a route to health self-reliance.
Ghana is an outlier
The health policy tracker KFF counted 35 countries that had signed the new US health agreements by 11 September 2026, most of them African. Nigeria and Uganda signed in December 2025, with terms reported to allow access to sensitive health data and pathogen specimens, in some cases covering up to 25 years of patient records. Kenya, Tanzania and Rwanda also signed. Zimbabwe and Namibia declined.
Human Rights Watch reviewed seven of the agreements and concluded that aid was being tied to surveillance data and rights over pathogen samples, with patient information potentially reaching US pharmaceutical companies without consent. Those findings relate to other countries' deals, not Ghana's draft.
Refusing is not protecting
A commentary published by Adom Online argues that the harder work begins now. Ghana has the Data Protection Act, 2012 (Act 843), which created the Data Protection Commission, and the Cybersecurity Act, 2020 (Act 1038), which established the Cyber Security Authority. But many health facilities still rely on paper files or disconnected systems, staff share logins, and few records are encrypted or audited.
The chairman of Parliament's health committee has described individual medical data as a red line, while accepting that aggregate figures such as district case counts are essential for outbreak control.
For Ghanaians abroad whose relatives use public clinics, the practical test is simple: who can see a patient's record, who has already seen it, and what happens if it leaks.
